Development and testing of a polygenic risk score for breast cancer aggressiveness.
Saved in:
| Title: | Development and testing of a polygenic risk score for breast cancer aggressiveness. |
|---|---|
| Authors: | Shieh Y; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. yis4001@med.cornell.edu., Roger J; PhD Program in Biological and Medical Informatics, University of California, San Francisco, San Francisco, CA, USA., Yau C; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA., Wolf DM; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA., Hirst GL; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA., Swigart LB; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA., Huntsman S; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Hu D; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Nierenberg JL; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Middha P; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Heise RS; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Shi Y; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Kachuri L; Department of Epidemiology and Population Health, Stanford University, Stanford, CA, USA., Zhu Q; Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA., Yao S; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Kwan ML; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Caan BJ; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Witte JS; Department of Epidemiology and Population Health, Stanford University, Stanford, CA, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., 't Veer LV; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA., Esserman LJ; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA., Ziv E; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2023 May 15; Vol. 7 (1), pp. 42. Date of Electronic Publication: 2023 May 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-023-00382-z |
